Temporal stability and responsiveness of the Montreal Cognitive Assessment following acquired brain injury
| Autor: | Alison M. McLean, Patricia Annabelle Lim, Grant L. Iverson, Noah D. Silverberg, Daniel DeForge, Christiane Kilpatrick |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Adult
Male medicine.medical_specialty Pediatrics Psychometrics Traumatic brain injury medicine.medical_treatment Neuroscience (miscellaneous) Poison control Neuropsychological Tests 03 medical and health sciences Cognition 0302 clinical medicine Brain Injuries Traumatic Developmental and Educational Psychology medicine Humans 030212 general & internal medicine Acquired brain injury Stroke Language Rehabilitation business.industry Reproducibility of Results Montreal Cognitive Assessment Middle Aged medicine.disease Treatment Outcome Physical therapy Receptive aphasia Female Neurology (clinical) Cognition Disorders business 030217 neurology & neurosurgery |
| Zdroj: | Brain Injury. 30:29-35 |
| ISSN: | 1362-301X 0269-9052 |
| DOI: | 10.3109/02699052.2015.1079732 |
| Popis: | To evaluate the temporal stability and responsiveness of the Montreal Cognitive Assessment (MoCA) in acquired brain injury (ABI).English-speaking adults with stroke or moderate-to-severe traumatic brain injury were administered alternate forms of the MoCA (version 1, then 2), 6 weeks apart. Chronic group participants (n = 40) were community-dwelling, at least 1 year post-ABI (mean = 12.1 years, SD = 9.0), and presumed clinically stable. Sub-acute group participants (n = 36) were 30.8 days post-ABI (SD = 12.4) and were undergoing intensive rehabilitation. Individuals with an unstable medical or psychiatric condition or severe receptive aphasia were not eligible.The chronic group scored 21.6 (SD = 4.5) initially and 22.7 (SD = 3.8) on the second administration, demonstrating a small but significant practise effect (p = 0.009). The Pearson test-re-test correlation coefficient was 0.83. Using reliable change methodology in the chronic group, the 80% confidence interval (CI) for change across the two administrations was -2 to +4, adjusting for practise. Applied to the sub-acute group, 39% improved and 0% declined.The MoCA is a brief standardized tool that appears useful for monitoring cognitive change after ABI. The findings enable clinicians to detect statistically reliable change across serial MoCA administrations in individuals with an ABI. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|